These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

205 related items for PubMed ID: 27498578

  • 1. Indocyanine green retention is a potential prognostic indicator after splenectomy and pericardial devascularization for cirrhotic patients.
    Zhang YB, Lu Y, Wu WD, Zhang CW, Shen GL, Hong dF.
    Hepatobiliary Pancreat Dis Int; 2016 Aug; 15(4):386-90. PubMed ID: 27498578
    [Abstract] [Full Text] [Related]

  • 2. Modified laparoscopic splenectomy and azygoportal disconnection combined with cell salvage is feasible and might reduce the need for blood transfusion.
    Jiang GQ, Bai DS, Chen P, Qian JJ, Jin SJ, Yao J, Wang XD.
    World J Gastroenterol; 2014 Dec 28; 20(48):18420-6. PubMed ID: 25561811
    [Abstract] [Full Text] [Related]

  • 3. Indocyanine green clearance test combined with MELD score in predicting the short-term prognosis of patients with acute liver failure.
    Feng HL, Li Q, Wang L, Yuan GY, Cao WK.
    Hepatobiliary Pancreat Dis Int; 2014 Jun 28; 13(3):271-5. PubMed ID: 24919610
    [Abstract] [Full Text] [Related]

  • 4. Indocyanine green retention test (ICG-r15) as a noninvasive predictor of portal hypertension in patients with different severity of cirrhosis.
    Pind ML, Bendtsen F, Kallemose T, Møller S.
    Eur J Gastroenterol Hepatol; 2016 Aug 28; 28(8):948-54. PubMed ID: 27172450
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. The combination of indocyanine green clearance test and model for end-stage liver disease score predicts early graft outcome after liver transplantation.
    Yunhua T, Weiqiang J, Maogen C, Sai Y, Zhiheng Z, Dongping W, Zhiyong G, Xiaoshun H.
    J Clin Monit Comput; 2018 Jun 28; 32(3):471-479. PubMed ID: 28831767
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Open Radiofrequency Ablation Combined with Splenectomy and Pericardial Devascularization vs. Liver Transplantation for Hepatocellular Carcinoma Patients with Portal Hypertension and Hypersplenism: A Case-Matched Comparative Study.
    Wang X, Sun X, Lei Y, Pei J, Ma K, Feng K, Lau WY, Xia F.
    J Invest Surg; 2023 Dec 28; 36(1):1-7. PubMed ID: 36345736
    [Abstract] [Full Text] [Related]

  • 9. Transjugular intrahepatic portosystemic shunt versus open splenectomy and esophagogastric devascularization for portal hypertension with recurrent variceal bleeding.
    Su AP, Zhang ZD, Tian BL, Zhu JQ.
    Hepatobiliary Pancreat Dis Int; 2017 Apr 28; 16(2):169-175. PubMed ID: 28381381
    [Abstract] [Full Text] [Related]

  • 10. Individualized Laparoscopic Therapy for Portal Hypertension: A Preliminary Single Center Experience.
    Bai DS, Yang KS, Jiang GQ, Qian JJ, Chen P, Jin SJ.
    J Laparoendosc Adv Surg Tech A; 2017 Feb 28; 27(2):121-127. PubMed ID: 27715476
    [Abstract] [Full Text] [Related]

  • 11. Prognostic Value of Metabolic Liver Function Tests: a Study on 711 Cirrhotic Patients.
    Lebossé F, Guillaud O, Forestier J, Ecochard M, Boillot O, Roman S, Mion F, Dumortier J.
    J Gastrointestin Liver Dis; 2016 Sep 28; 25(3):337-43. PubMed ID: 27689198
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Laparoscopic azygoportal disconnection with and without splenectomy for portal hypertension.
    Bai DS, Qian JJ, Chen P, Xia BL, Jin SJ, Zuo SQ, Jiang GQ.
    Int J Surg; 2016 Oct 28; 34():116-121. PubMed ID: 27568650
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Effect of surgery treatment on hypersplenism caused by cirrhotic portal hypertension.
    Lv YF, Li XQ, Gong XG, Xie XH, Han XY, Wang BC.
    Minerva Chir; 2013 Aug 28; 68(4):409-13. PubMed ID: 24019049
    [Abstract] [Full Text] [Related]

  • 16. Retrospective Study to Compare Selective Decongestive Devascularization and Gastrosplenic Shunt versus Splenectomy with Pericardial Devascularization for the Treatment of Patients with Esophagogastric Varices Due to Cirrhotic Portal Hypertension.
    Bao H, He Q, Dai N, Ye R, Zhang Q.
    Med Sci Monit; 2017 Jun 08; 23():2788-2795. PubMed ID: 28594784
    [Abstract] [Full Text] [Related]

  • 17. Adverse factors responsible for below-normal platelet count after laparoscopic splenectomy and azygoportal disconnection.
    Bai DS, Shao WY, Zhang C, Chen P, Jin SJ, Jiang GQ.
    Turk J Gastroenterol; 2019 Mar 08; 30(3):254-259. PubMed ID: 30460896
    [Abstract] [Full Text] [Related]

  • 18. Predicting portal hypertension and variceal bleeding using non-invasive measurements of metabolic variables.
    Eslam M, Ampuero J, Jover M, Abd-Elhalim H, Rincon D, Shatat M, Camacho I, Kamal A, Lo Iacono O, Nasr Z, Grande L, Banares R, Khattab MA, Romero-Gomez M.
    Ann Hepatol; 2013 Mar 08; 12(4):588-98. PubMed ID: 23813137
    [Abstract] [Full Text] [Related]

  • 19. Incidence and risk factors associated with a high comprehensive complication index score after splenectomy in cirrhotic patients with hypersplenism.
    Du Z, Dong J, Zhang J, Bi J, Wu Z, Lv Y, Zhang X, Wu R.
    J Surg Res; 2018 Feb 08; 222():69-74. PubMed ID: 29273377
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.